Banner

AI In Pharma Global Market Report 2023 – By Technology (Context Aware Processing, Natural Language Processing, Querying Method, Deep Learning), By Drug Type (Small Molecule, Large Molecules), By Application (Diagnosis, Clinical Trial Research, Drug Discovery, Research and Development, Epidemic Prediction) – Market Size, Trends, And Global Forecast 2023-2032

Starting Price : $4000.00 | Pages : 200 | Published : January 2023 | SKU CODE : r852 | Delivery Time: 2-3 business days | Format :


AI in pharma refers to the use of automated algorithms to jobs that normally need human intelligence. Large datasets including disease patterns can be successfully identified by AI solutions in pharma, and they can also assist in understanding which medication formulations would be most effective for treating certain ailments.

The artificial intelligence (AI) in the pharma market covered in the report is segmented by technology into context-aware processing, natural language processing, querying method, and deep learning; by drug type into the small molecule, large molecules; by application into diagnosis, clinical trial research, drug discovery, research and development, epidemic prediction.

The artificial intelligence (AI) in pharma market research report is one of a series of new reports from The Business Research Company that provides artificial intelligence (AI) in pharma market statistics, including artificial intelligence (AI) in pharma industry global market size, regional shares, competitors with artificial intelligence (AI) in pharma market share, detailed artificial intelligence (AI) in pharma market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence (AI) in pharma industry. This artificial intelligence (AI) in pharma market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The global AI in pharma market size grew from $1.24 billion in 2022 to $1.64 billion in 2023 at a compound annual growth rate (CAGR) of 32.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The AI in pharma market size is expected to grow to $4.61 billion in 2027 at a CAGR of 29.4%.

The growing adoption of artificial intelligence (AI) for clinical trials research is driving its demand for AI in the pharmaceutical market. To bring a new drug to the market takes on an average 10–15 years approximately and half of this time is consumed during the clinical trial phases of the drug development cycle. Hence, using AI models and analytics tools can accelerate the clinical trial phases, perception of diseases, identify suitable cases and key investigators to inform site selection, and support novel clinical study designs. For instance, in January 2020, Pfizer, an American pharmaceutical company, tied up with a biotech startupInsilico Medicine to identify drug targets. With AI tools Pfizer can speed up drug discovery and reduce drug development costs in the drug development processes. Thus, increasing the adoption of AI for clinical trials research is driving AI in the pharma market.

A lack of skilled professionals may hamper the growth of artificial intelligence in the pharma market. In 2022, according to the report published by UNLEASH, a UK-based digital media platform, IBM, and Morning Consult conducted surveys of more than 1,000 tech job seekers, more than 600 tech workers, and more than 300 tech recruiters in the UK, Spain, and Germany to determine the AI skills gap in Europe and found around 28% of recruiters report having difficulty locating candidates with deep learning, machine learning, and data engineering and analytics experience. The shortage of AI skills is seen as a major barrier to the pace of technology’s adoption. In fact, 56% of senior AI professionals thought that a lack of additional, qualified AI workers was the single most important hurdle to be overcome in terms of obtaining the necessary level of AI implementation beyond business operations. Therefore, the lack of skilled professionals may hamper the growth of AI in the pharma market.

Companies operating in the AI for the pharma market are introducing new AI tools that will be beneficial for the pharma companies and this is a key trend in AI in the pharma market. AI helps in quality control, predictive maintenance, waste reduction, design optimization, and process automation. For instance, in August 2022, Sanford Health, a US-based non-profit, integrated healthcare delivery system,and Sharp HealthCare, a US-based non-profit organization in healthcarepartnered with Dandelion Health, a US-based healthcare artificial intelligence (AI) company, introduced a comprehensive data platform that gives health institutions access to high-quality, representative patient data for clinical AI development. The Dandelion Platform is made to give health AI developers secure, ethical access to patient datasets which includes include images, waveforms, and structured health records, so they may make tools and products that will help patients and clinicians.

In October 2021, Nurosene Health Inc., a Canada-based company focused on delivering innovative AI-based technology solutions that support mental performance and wellness acquired Netramark Incorporated for an undisclosed amount. Through this acquisition, Nurosene Health Inc aims to strengthen its capabilities in AI-based neuroscience product offerings. Netramark Incorporated is a Canada-based pharma tech company that utilizes AI, novel mathematical methods, and quantum computing to optimize new drug development, clinical trials, treatment, and diagnosis.

Major players in the AI in pharma market are Novartis, IBM Watson, Microsoft Corporation, Merck, GNS Healthcare., Google, AstraZeneca, Atomwise, Inc., Exscientia, and Cyclica.

North America was the largest region in the AI in pharma market in 2022. The regions covered in the AI in pharma market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The countries covered in the AI in pharma market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The AI in pharma market includes revenues earned by entities by implementing quality control, addressing supply chain problems in the production line, and minimising material waste. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The global ai in pharma market is segmented -

1) By Technology: Context-Aware Processing, Natural Language Processing, Querying Method, Deep Learning

2) By Drug Type: Small Molecule, Large Molecules

3) By Application: Diagnosis, Clinical Trial Research, Drug Discovery, Research and Development, Epidemic Prediction

    Table Of Contents

    1. Executive Summary

    2. AI in Pharma Market Characteristics

    3. AI in Pharma Market Trends And Strategies

    4. AI in Pharma Market - Macro Economic Scenario

    4.1. COVID-19 Impact On AI in Pharma Market

    4.2. Ukraine-Russia War Impact On AI in Pharma Market

    4.3. Impact Of High Inflation On AI in Pharma Market

    5. AI in Pharma Market Size And Growth

    5.1. Global AI in Pharma Historic Market, 2017-2022, $ Billion

    5.1.1. Drivers Of The Market

    5.1.2. Restraints On The Market

    5.2. Global AI in Pharma Forecast Market, 2022-2027F, 2032F, $ Billion

    5.2.1. Drivers Of The Market

    5.2.2. Restraints On the Market

    6. AI in Pharma Market Segmentation

    6.1. Global AI in Pharma Market, Segmentation Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Context-Aware Processing

    Natural Language Processing

    Querying Method

    Deep Learning

    6.2. Global AI in Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Small Molecule

    Large Molecules

    6.3. Global AI in Pharma Market, Segmentation By Application:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Diagnosis

    Clinical Trial Research

    Drug Discovery

    Research and Development

    Epidemic Prediction

    7. AI in Pharma Market Regional And Country Analysis

    7.1. Global AI in Pharma Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    7.2. Global AI in Pharma Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    8. Asia-Pacific AI in Pharma Market

    8.1. Asia-Pacific AI in Pharma Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific AI in Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    8.3. Asia-Pacific AI in Pharma Market, Segmentation By Application:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    9. China AI in Pharma Market

    9.1. China AI in Pharma Market Overview

    9.2. China AI in Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

    9.3. China AI in Pharma Market, Segmentation By Application:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

    10. India AI in Pharma Market

    10.1. India AI in Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    10.2. India AI in Pharma Market, Segmentation By Application:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    11. Japan AI in Pharma Market

    11.1. Japan AI in Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    11.2. Japan AI in Pharma Market, Segmentation By Application:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    12. Australia AI in Pharma Market

    12.1. Australia AI in Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    12.2. Australia AI in Pharma Market, Segmentation By Application:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    13. Indonesia AI in Pharma Market

    13.1. Indonesia AI in Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    13.2. Indonesia AI in Pharma Market, Segmentation By Application:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    14. South Korea AI in Pharma Market

    14.1. South Korea AI in Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    14.2. South Korea AI in Pharma Market, Segmentation By Application:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    15. Western Europe AI in Pharma Market

    15.1. Western Europe AI in Pharma Market Overview

    15.2. Western Europe AI in Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    15.3. Western Europe AI in Pharma Market, Segmentation By Application:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    16. UK AI in Pharma Market

    16.1. UK AI in Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    16.2. UK AI in Pharma Market, Segmentation By Application:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    17. Germany AI in Pharma Market

    17.1. Germany AI in Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    17.2. Germany AI in Pharma Market, Segmentation By Application:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    18. France AI in Pharma Market

    18.4. France AI in Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    18.5. France AI in Pharma Market, Segmentation By Application:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    19. Eastern Europe AI in Pharma Market

    19.1. Eastern Europe AI in Pharma Market Overview

    19.2. Eastern Europe AI in Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    19.3. Eastern Europe AI in Pharma Market, Segmentation By Application:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    20. Russia AI in Pharma Market

    20.1. Russia AI in Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    20.2. Russia AI in Pharma Market, Segmentation By Application:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    21. North America AI in Pharma Market

    21.1. North America AI in Pharma Market Overview

    21.2. North America AI in Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    21.3. North America AI in Pharma Market, Segmentation By Application:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    22. USA AI in Pharma Market

    22.1. USA AI in Pharma Market Overview

    22.2. USA AI in Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    22.3. USA AI in Pharma Market, Segmentation By Application:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    23. South America AI in Pharma Market

    23.1. South America AI in Pharma Market Overview

    23.2. South America AI in Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    23.3. South America AI in Pharma Market, Segmentation By Application:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    24. Brazil AI in Pharma Market

    24.1. Brazil AI in Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    24.2. Brazil AI in Pharma Market, Segmentation By Application:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    25. Middle East AI in Pharma Market

    25.1. Middle East AI in Pharma Market Overview

    25.2. Middle East AI in Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    25.3. Middle East AI in Pharma Market, Segmentation By Application:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    26. Africa AI in Pharma Market

    26.1. Africa AI in Pharma Market Overview

    26.2. Africa AI in Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    26.3. Africa AI in Pharma Market, Segmentation By Application:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    27. AI in Pharma Market Competitive Landscape And Company Profiles

    27.1. AI in Pharma Market Competitive Landscape

    27.2. AI in Pharma Market Company Profiles

    27.2.1. Novartis

    27.2.1.1. Overview

    27.2.1.2. Products and Services

    27.2.1.3. Strategy

    27.2.1.4. Financial Performance

    27.2.2. IBM Watson

    27.2.2.1. Overview

    27.2.2.2. Products and Services

    27.2.2.3. Strategy

    27.2.2.4. Financial Performance

    27.2.3. Microsoft Corporation

    27.2.3.1. Overview

    27.2.3.2. Products and Services

    27.2.3.3. Strategy

    27.2.3.4. Financial Performance

    27.2.4. Merck

    27.2.4.1. Overview

    27.2.4.2. Products and Services

    27.2.4.3. Strategy

    27.2.4.4. Financial Performance

    27.2.5. GNS Healthcare.

    27.2.5.1. Overview

    27.2.5.2. Products and Services

    27.2.5.3. Strategy

    27.2.5.4. Financial Performance

    28. Key Mergers And Acquisitions In The AI in Pharma Market

    29. AI in Pharma Market Future Outlook and Potential Analysis

    30. Appendix

    30.1. Abbreviations

    30.2. Currencies

    30.3. Historic And Forecast Inflation Rates

    30.4. Research Inquiries

    30.5. The Business Research Company

    30.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Table 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Table 3: Global AI in Pharma Market, Segmentation Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 4: Global AI in Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 5: Global AI in Pharma Market, Segmentation By Application:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 6: Global AI in Pharma Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 7: Global AI in Pharma Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 8: Asia-Pacific, AI in Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 9: Asia-Pacific, AI in Pharma Market, Segmentation By Application:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 10: China, AI in Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 11: China, AI in Pharma Market, Segmentation By Application:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 12: India, AI in Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 13: India, AI in Pharma Market, Segmentation By Application:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 14: Japan, AI in Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 15: Japan, AI in Pharma Market, Segmentation By Application:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 16: Australia, AI in Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 17: Australia, AI in Pharma Market, Segmentation By Application:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 18: Indonesia, AI in Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 19: Indonesia, AI in Pharma Market, Segmentation By Application:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 20: South Korea, AI in Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 21: South Korea, AI in Pharma Market, Segmentation By Application:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 22: Western Europe, AI in Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 23: Western Europe, AI in Pharma Market, Segmentation By Application:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 24: UK, AI in Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 25: UK, AI in Pharma Market, Segmentation By Application:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 26: Germany, AI in Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 27: Germany, AI in Pharma Market, Segmentation By Application:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 28: France, AI in Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 29: France, AI in Pharma Market, Segmentation By Application:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 30: Eastern Europe, AI in Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 31: Eastern Europe, AI in Pharma Market, Segmentation By Application:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 32: Russia, AI in Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 33: Russia, AI in Pharma Market, Segmentation By Application:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 34: North America, AI in Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 35: North America, AI in Pharma Market, Segmentation By Application:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 36: USA, AI in Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 37: USA, AI in Pharma Market, Segmentation By Application:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 38: South America, AI in Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 39: South America, AI in Pharma Market, Segmentation By Application:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 40: Brazil, AI in Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 41: Brazil, AI in Pharma Market, Segmentation By Application:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 42: Middle East, AI in Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 43: Middle East, AI in Pharma Market, Segmentation By Application:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 44: Africa, AI in Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 45: Africa, AI in Pharma Market, Segmentation By Application:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 46: Novartis Financial Performance
  • Table 47: IBM Watson Financial Performance
  • Table 48: Microsoft Corporation Financial Performance
  • Table 49: Merck Financial Performance
  • Table 50: GNS Healthcare. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Figure 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Figure 3: Global AI in Pharma Market, Segmentation Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 4: Global AI in Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 5: Global AI in Pharma Market, Segmentation By Application:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 6: Global AI in Pharma Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 7: Global AI in Pharma Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 8: Asia-Pacific, AI in Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 9: Asia-Pacific, AI in Pharma Market, Segmentation By Application:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 10: China, AI in Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 11: China, AI in Pharma Market, Segmentation By Application:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 12: India, AI in Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 13: India, AI in Pharma Market, Segmentation By Application:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 14: Japan, AI in Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 15: Japan, AI in Pharma Market, Segmentation By Application:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 16: Australia, AI in Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 17: Australia, AI in Pharma Market, Segmentation By Application:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 18: Indonesia, AI in Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 19: Indonesia, AI in Pharma Market, Segmentation By Application:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 20: South Korea, AI in Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 21: South Korea, AI in Pharma Market, Segmentation By Application:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 22: Western Europe, AI in Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 23: Western Europe, AI in Pharma Market, Segmentation By Application:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 24: UK, AI in Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 25: UK, AI in Pharma Market, Segmentation By Application:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 26: Germany, AI in Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 27: Germany, AI in Pharma Market, Segmentation By Application:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 28: France, AI in Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 29: France, AI in Pharma Market, Segmentation By Application:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 30: Eastern Europe, AI in Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 31: Eastern Europe, AI in Pharma Market, Segmentation By Application:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 32: Russia, AI in Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 33: Russia, AI in Pharma Market, Segmentation By Application:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 34: North America, AI in Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 35: North America, AI in Pharma Market, Segmentation By Application:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 36: USA, AI in Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 37: USA, AI in Pharma Market, Segmentation By Application:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 38: South America, AI in Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 39: South America, AI in Pharma Market, Segmentation By Application:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 40: Brazil, AI in Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 41: Brazil, AI in Pharma Market, Segmentation By Application:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 42: Middle East, AI in Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 43: Middle East, AI in Pharma Market, Segmentation By Application:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 44: Africa, AI in Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 45: Africa, AI in Pharma Market, Segmentation By Application:, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 46: Novartis Financial Performance
  • Figure 47: IBM Watson Financial Performance
  • Figure 48: Microsoft Corporation Financial Performance
  • Figure 49: Merck Financial Performance
  • Figure 50: GNS Healthcare. Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report